Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-01-10
1998-08-25
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514212, 5142345, 514255, 514307, 514403, A61K 31445
Patent
active
057983674
ABSTRACT:
Indazolecarboxamides are used as antagonists and partial agonists for the serotonin receptor 5-HT.sub.4 and provide therapeutic methods for treatment of disorders caused by or affected by dysfunction of the 5-HT.sub.4 receptor.
REFERENCES:
patent: 3145215 (1964-08-01), Kirchner
patent: 5552398 (1996-09-01), King
Bockaert et al. "The 5ht4 receptor: a place in the sun" RIPS reviews, v. 13, pp. 141-145, 1992.
Taniyama et al. "Cisapride stimulates motility of the instetine via the 5HT receptors" Embase abst. No. 91337334, 1991.
Feletou et al. "Serotoninergic receptors subtype in coronary artery smooth muscle . . . " Medline Abst. 94133110, 1994.
Gidener et al. "Influence of serotnin on the human ureter . . . " Medline Abst. 96160103, 1996.
Miyashita et al. "A novel specific 5HT4 receptor . . . " Derwent Drug Abst. 92-33552, 1995.
Robert W. Hamilton, J. Heterocyclic Chem., 13, 545-553.
Kaumann, et al., Bio. Med. Chem. Let., 2, 419-420 (1992).
Derwent Abstract, Belgium 770068 (1970).
Derwent Abstract, Japanese 8081-858 (1972).
Catlow John T.
Cohen Marlene L.
Martinelli Michael J.
Schaus John M.
Swanson Steven
Boone David E.
Chang Ceila
Eli Lilly and Company
Titus Robert D.
LandOfFree
Indazolecarboxamides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indazolecarboxamides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indazolecarboxamides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-36587